Stay updated on Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    No significant changes detected; only minor display tweaks and a timestamp update were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:08:56.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    3%
    Check dated 2025-10-05T10:05:48.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0: version metadata updated; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:14:32.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Core update: the page now displays Revision: v3.0.2, replacing v3.0.1. Removal of the 'Back to Top' element is a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T17:36:49.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T14:59:32.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific drug information for Tislelizumab and HMPL-013, as well as detailed location information for facilities in Tianjin and South Korea. The revision number has also been updated to v3.0.0.
    Difference
    2%
    Check dated 2025-08-30T11:47:59.000Z thumbnail image

Stay in the know with updates to Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.